COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
NIH staff guidance on coronavirus (NIH Only)

You are here

Find NINDS Clinical Trials

Find NINDS Clinical Trials

Subscribe to Find NINDS Clinical Trials

RSS

XLSX

Returning 1240 results

Study Title	Location	Status	Disorders
Antihypertensive Treatment in Acute Cerebral Hemorrhage	Multiple U.S. Locations	Completed	Intracerebral Hemorrhage, Hypertension, Stroke
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II	International Locations	Terminated	Intracerebral Hemorrhage
Antiplatelet Therapy to Prevent Stroke in African Americans	Illinois	Completed	Stroke, Cerebral Infarction
Approaches and Decisions for Acute Pediatric TBI Trial	Multiple U.S. Locations	Completed	Severe Traumatic Brain Injury
Areas of Brain Responsible for Understanding American Sign Language	Maryland	Completed	Brain Mapping, Deafness, Healthy
Arm Rehabilitation Study After Stroke	Multiple U.S. Locations	Completed	Stroke, Brain Infarction, Brain Ischemia, Cerebral Infarction, Cerebrovascular Disorders
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)	Multiple U.S. Locations	Recruiting	Frontotemporal Lobar Degeneration (FTLD), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Behavioral Variant Frontotemporal Dementia (bvFTD), Semantic Variant Primary Progressive Aphasia (svPPA), Nonfluent Variant Primary Progressive Aphasia (nfvPPA), FTD With Amyotrophic Lateral Sclerosis (FTD/ALS), Amyotrophic Lateral Sclerosis, Oligosymptomatic PSP (oPSP)
Aspirin Or Warfarin To Prevent Stroke	Georgia	Terminated	Stroke, Cerebral Infarction, Atherosclerosis, Constriction, Pathologic
Aspirin Prophylaxis in Sickle Cell Disease	No documented Location	Completed	Sickle Cell Disease
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)	Maryland*	Recruiting	Myotonic Dystrophy Type-1, Myotonic Dystrophy Type-2

Pages